Welcome back to Stockhouse
Member Sign In

Email or Username:

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Enter your email address:
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History  |  Analysts  |  Earnings  |  Insiders

Tekmira Pharmaceuticals Corp T.TKM

Sector: Healthcare | Sub-Sector: Biotechnology
Alternate Symbol(s):  TKMR

Tekmira Pharmaceuticals Corp develops ribonucleic acid interference therapeutic product candidates as well as provides its lipid nanoparticle delivery technology to pharmaceutical partners in the Canada.
Price: $31.19 | Change: +$0.79 | %Change: +2.60%
Volume: 113,558 | Day High/Low: 32.30/29.98 | 52 Week High/Low: 34.66/9.55
View modes: 
1 star

Phase 1

21 Jan 2015 08:38 ET GlobeNewswire Tekmira Pharmaceuticals Corporation (Nasdaq:TKMR) (TSX:TKM), a leading developer of RNA interference (RNAi) therapeutics, announced today that more
3 stars

RE: RA Capital Management Discloses 10% Passive Stake

RA Capital also holds 7.9% through RA Capital Healthcare, and Peter Kolchinski ( the manager ) holds a further 9.9% bring total holdings to 6,204,064 shares, or 27.7%.... according to StockTwits.  rate and reply
3 stars

RE: RA Capital Management Discloses 10% Passive Stake

They actually disclosed a 9.9% stake. Today, after the close, Falconedge disclosed a 9.9% stake.   The reason for the 9.9% is that under US reporting rules, at 10% they become classified as "insiders" more
1 star

RA Capital Management Discloses 10% Passive Stake

[url= ]Shares bought by RA[/url] Cool.  :)  rate and reply
1 star


Vesuvius buried Pompeii. Tekmira will bury the shorts.  rate and reply
1 star


Tekmira is a first rate company with an exceedingly bright future. The problem is that the world is in entropy. The fundamentals are as bad as the global geopolitcal situation. European contagion is more
3 stars

RE:Tekmira.....$billion company!

When this deal closes in 2-3 months, Tekmira will have approximately twice as many shares outstanding, so the company will be capped at $1.2bb if prices stay where they are today... which they more
1 star

Tekmira.....$billion company!

Interesting article Buckle up.  :)  rate and reply
1 star

Oncore= Shark Reppellant

Oncore saw TKM and low float. Great move. Not a bunch of whiners. Welcome Aboard Oncore Oncology  rate and reply
1 star

Any crazy azzs

gonna jump on for the ride  go TKM baby risk vs. reward peace  rate and reply
1 star

RE:A little dip...

Don't expect oil to go higher than $55 for another year or so. :(  rate and reply
1 star

A little dip...

...little normal it dips a bit after a HUGE upswing the day before. Will swing back little by little as of Thursday or Friday. Might go down a bit more tomorrow, but not by much I am guessing! more
2 stars

About OnCore Biopharma

OnCore Biopharma, Inc. is a privately held biotechnology company focused on the research, development, and commercialization of therapies for the treatment of chronic Hepatitis B virus (HBV) more
1 star


RNAI Therapuetics Blog glad the hype over the Ebola vaccine is done,time to make some real $$$$$  :)  rate and reply
0 stars

Nice surprise!!!

Cheers to all!!  rate and reply
1 star

RE:Jan 12, 2015 Up + 38%

thnx man peace  rate and reply
1 star

Jan 12, 2015 Up + 38%

Great day to be a Tekmira shareholder. Congradulations...  rate and reply
3.5 stars

News Out

BUZZ-Tekmira Pharmaceuticals: Acquisition to boost Hep B drugs portfolio ** Canadian biopharmaceutical company's U.S.-listed shares up 43 pct at $22.40 premarket ** Tekmira to buy OnCore Biopharma more
1 star

hmm West Coast

0420 am up 42.0 percent  pre market good sign peace  rate and reply
1 star

RE:tkm Merger news..

percent  rate and reply